Walgreens Boots Alliance, Inc. (WBA) Shares Sold by Gibraltar Capital Management Inc.

Gibraltar Capital Management Inc. lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 42,860 shares of the pharmacy operator’s stock after selling 339 shares during the period. Walgreens Boots Alliance comprises approximately 3.4% of Gibraltar Capital Management Inc.’s investment portfolio, making the stock its 15th biggest holding. Gibraltar Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $3,356,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Hudock Capital Group LLC raised its stake in Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 5 shares in the last quarter. Tarbox Group Inc. raised its stake in Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares in the last quarter. Webster Bank N. A. raised its stake in Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares in the last quarter. MCF Advisors LLC raised its stake in Walgreens Boots Alliance by 68.2% in the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after buying an additional 780 shares in the last quarter. Finally, Founders Capital Management bought a new position in Walgreens Boots Alliance in the first quarter worth approximately $161,000. 60.16% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages recently commented on WBA. Needham & Company LLC reissued a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Saturday. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, June 14th. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, UBS AG reissued a “buy” rating and issued a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $91.81.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 13.50% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: This story was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2017/09/18/walgreens-boots-alliance-inc-wba-shares-sold-by-gibraltar-capital-management-inc.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.61% during midday trading on Monday, hitting $83.00. 2,000,584 shares of the stock were exchanged. The stock has a 50 day moving average price of $81.26 and a 200-day moving average price of $81.99. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $88.00. The company has a market cap of $88.82 billion, a PE ratio of 20.96 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period last year, the business earned $1.18 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 EPS for the current year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback program on Thursday, June 29th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were paid a dividend of $0.40 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.92%. The ex-dividend date was Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 40.30%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply